Delivery Order SPE2DE24DA017-SPE2D625F1GT0
- Not listed
- This delivery order, valued at $2,201.10, was awarded to Arthrex Inc. on August 27, 2025, for the supply of bio-composite swivel cannula measuring 4.75x19.1mm, an orthopedic surgical instrument component. The contract is a fixed-price award with economic price adjustment provisions and carries an ultimate completion date of September 2, 2025. The delivery order was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for procuring medical...
- The U.S. Department of Defense's Medical Supply Chain awarded Arthrex Inc. a delivery order for surgical cannula instruments valued at $1,016.60, effective January 20, 2026, with completion scheduled for January 23, 2026. The contract carries fixed-price pricing with economic price adjustment provisions and includes no set-aside designation, reflecting Arthrex's competitive standing in federal orthopedic procurement. Performance will occur at the contractor's Naples, Florida headquarters. This...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $9,893.04 by the Defense Logistics Agency's Medical Supply Chain for BIO-COMP swivel cannula (4.75 x 19.1 mm) with an ultimate completion date of February 2, 2026. This fixed-price contract with economic price adjustment was awarded on January 28, 2026, without set-aside designation, reflecting Arthrex's strong competitive...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1,109.20 to Arthrex Inc. for the procurement of twist-in cannulas. This fixed-price delivery order with economic price adjustment authority was executed on November 4, 2025, with an ultimate completion date of November 7, 2025. The award carries no set-aside designation, reflecting Arthrex's competitive position in federal orthopedic medical device procurement. Performance will occur at Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,642.16 from the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, for a 2.75mm cannulation drill with a .066-inch specification. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of July 29, 2025. This award was not set aside for any specific business...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies based in Naples, Florida, was awarded a delivery order valued at $1,379.40 for a Low Profile Cannula Percutaneous Kit on September 2, 2025. This fixed-price delivery order with economic price adjustment clause is not set aside for any specific business type and is expected to be completed by September 5, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented...
- This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,336.75 fixed-price delivery order contract is for the supply of CANNULA, TWIST-IN medical devices. The contract has an ultimate completion date of November 13, 2024. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company holds a significant single-award...
- This is a federal contract award from the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract, valued at $6,187.76, is for the delivery of open cannulas, blunt, curved, and low-profile medical supplies. The contract has a fixed-price with economic price adjustment pricing structure and a completion date of January 28, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,377.65 fixed-price delivery order to Arthrex Inc. for a Bio-Comp Swivelock C orthopedic implant (CLD 5.5x19.1mm) on November 14, 2025, with completion targeted for November 19, 2025. This delivery order was issued without a set-aside designation and is being performed at Arthrex's Naples, Florida facility. The award represents a task order under Arthrex's existing Indefinite Delivery Contract SPE2DE24D0020 with the Medical Supply...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,252.37 on May 28, 2025, for a 2.75mm cannulation drill with a .066 specification. This fixed-price delivery order with economic price adjustment is part of Arthrex's broader relationship with the Defense Logistics Agency's Medical Supply Chain, which falls under the Department of Defense. The contract will be performed in Naples, Florida, with an...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F1GT0Delivery Order
This delivery order, valued at $2,201.10, was awarded to Arthrex Inc. on June 9, 2025, by the Defense Logistics Agency's Medical Supply Chain for the provision of a Bio-Comp swiveling cannula measuring 4.75 x 19.1 millimeters. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by June 12, 2025. The award was made to the Naples, Florida-based orthopedic medical technology manufacturer under a non-competitive procurement, with no small business set-aside designation applied. Performance will take place at Arthrex's Naples facility. This delivery order falls under Arthrex's comprehensive Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, a $471 billion agreement running through September 2029 that provides Veterans Affairs medical centers nationwide access to the company's full portfolio of orthopedic surgical products and instruments. Arthrex, a leading global developer of minimally invasive orthopedic technologies, has demonstrated strong capacity to support federal healthcare systems through its existing contract awards exceeding $550,000 under this IDC vehicle. The Bio-Comp cannula represents a specialized surgical instrument consistent with the company's core business of supplying advanced orthopedic implants, arthroscopic tools, and surgical instrumentation to the Department of Defense and Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/9/25 |